Abeona Therapeutics Inc. (NASDAQ:ABEO) Q3 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Abeona Therapeutics Third Quarter 2023 Conference Call. [Operator Instructions]. Please note this conference is being recorded.
Abeona Therapeutics Inc. (ABEO)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Adage Capital Management Phill Gross And Robert Atchinson | 3,249,994 | $23,562,457 | 0.04% | |
| 2. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 2,310,640 | $16,752,140 | +3% | 0.95% |
| 3. | Millennium Management Israel Englander | 1,986,548 | $14,402,473 | +41% | 0% |
| 4. | Ikarian Capital Neil Shahrestani | 888,593 | $6,442,299 | +49% | 0.7% |
| 5. | Laurion Capital Management Benjamin A. Smith | 646,830 | $4,689,518 | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.71 | 11,000 | Director | 82,857 | 2024-05-16 | Filing | |
| $3.20 | 10,000 | Officer, Director | 538,260 | 2024-04-25 | Filing | |
| $3.28 | 7,550 | Director | 78,323 | 2024-04-26 | Filing | |
| $3.24 | 8,600 | Officer | 188,718 | 2024-04-25 | Filing | |
| $3.14 | 5,608 | Officer | 233,868 | 2024-04-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.51 | 25,890 | Director | 36,926 | 2024-06-18 | Filing | |
| $4.51 | 25,821 | Director | 62,063 | 2024-06-18 | Filing | |
| $5.11 | 7,084 | Director | 62,816 | 2024-01-17 | Filing | |
| $3.91 | 6,330 | Director | 87,884 | 2023-09-27 | Filing | |
| $3.91 | 6,316 | Director | 69,900 | 2023-09-27 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,101,131 | $5,516,667 | 0% | |
| 2. | 808,112 | $4,048,641 | 2.69% | |
| 3. | 450,347 | $2,256,238 | 0% | |
| 4. | 429,816 | $2,153,378 | 0.08% | |
| 5. | 219,385 | $1,099,392 | 0% |
News See All
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q2 2023 Earnings Call Transcript
Operator: Good day, and welcome to the Abeona Therapeutics Second Quarter 2023 Update Conference Call [Operator Instructions]. As a reminder, today's conference is being recorded.
5 Best Biotech Penny Stocks To Buy Now
In this article, we will be taking a look at the 5 best biotech penny stocks to buy now.
10 Best Penny Stocks to Buy in September
As the stock market runs red, investors are wary about spending copious amounts of money and making huge investments amid such macro uncertainty.
5 Biotech Penny Stocks to Buy According to Reddit
In this article, we discuss the 5 biotech penny stocks to buy according to Reddit.
10 Penny Stocks Robinhood Traders are Buying in 2021
In this article, we discuss the 10 penny stocks Robinhood traders are buying in 2021.
10 Best Stocks Under $5 in 2021
This article will take a look at the 10 best stocks under $5 in 2021.
Is ABEO A Good Stock To Buy Now?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities...
Abeona Therapeutics Inc (ABEO): Hedge Funds Taking Some Chips Off The Table
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Did Hedge Funds Make The Right Call On Abeona Therapeutics Inc (ABEO) ?
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC.
Billionaire Hedge Funds
